Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.

Perth will be hosting a major epigenetics conference in November. [ + ]

University of Queensland-based contract research organisation TetraQ is now recognised to provide internationally accredited testing services to the Australian biopharmaceutical industry.

Nominations for the 2008 ATSE Clunies Ross Awards, Australia’s awards for scientists, technologists and innovators, close on 31 July 2007.

DNA polymerase epsilon has a critical role in DNA replication, researchers find. [ + ]

All Australian patents are now freely searchable. [ + ]

Mesenchymal tem cells taken from fat tissue used to treat colon cancer. [ + ]

Monash uni is the first organisation outside of Europe to be given associate membership of EMBL. [ + ]

Mass spectrometry expert appointed new CEO of the Australian Research Council. [ + ]

An ambitious international effort has been launched to decode the genome of Eucalyptus, one of the world's most valuable fibre- and paper-producing trees - with the goal to maximise its potential in the burgeoning bio energy market and for capturing excess atmospheric carbon.

Following a decision by the European Molecular Biology Laboratory (EMBL) Council, Australia is set to be granted Associate Membership of EMBL.

NIH-funded trial of Starpharma's VivaGel microbicide under way in US. [ + ]

$331 million deal sees Roche move into RNAi-based therapeutics. [ + ]

New evidence supports theory that a breakdown in frontal temporal connectivity underlies schizophrenia. [ + ]

Professor Nicholas Fisk will head UQ's new clinical research centre. [ + ]